Brian Kim, MD

Clinical Associate Professor of Medicine (Clinician Educator)

Image of Brian Kim, MD
Is this your profile? Click to edit

Overview

Dr. Brian Kim is a transplant hepatologist specializing in the treatment of patients with acute and chronic liver disease, cirrhosis, and hepatocellular carcinoma. Dr. Kim is board certified in internal medicine, gastroenterology, and transplant hepatology. He is an active member of the American Association for the Study of Liver Diseases (AASLD) where he serves as a member of the AASLD Maintenance of Certification Committee. He is also a member of the American College of Gastroenterology (ACG) and serves on the ACG Training Committee. He is an American Board of Internal Medicine (ABIM) Governance Member and serves on the ABIM Gastroenterology Approval Committee.

Dr. Kim’s clinical research interests include liver transplantation, living donor liver transplantation, cardiac diseases in liver patients, and complications of portal hypertension. He has authored numerous chapters and articles in peer-reviewed journals on various topics in liver disease, liver transplantation, and education.

He currently serves as the Program Director for the ACGME-accredited Gastroenterology and Hepatology Fellowship at USC and also serves as the chair of the USC Keck School of Medicine GI/Liver Course.

He graduated with a Bachelor of Science in molecular, cellular, and developmental biology from Yale University. He received his MD from Columbia University College of Physicians and Surgeons. He completed his internship and residency training in internal medicine at Columbia University New York-Presbyterian Hospital. He then completed gastroenterology fellowship training at Johns Hopkins University School of Medicine and transplant hepatology fellowship training at Mount Sinai School of Medicine.

Awards

  • 1998
     -: National Merit Scholar, 1998
     – 1999
  • Yale Club of Chicago Foundation: Scholar, 1998
     – 1999
  • 1998
     -: Robert C. Byrd Scholar, 1998
     – 2002
  • Theodore F. Myers and Margaret B Myers: Scholar, 1999
     – 2000
  • 2001
     -: William Grey Warden Scholar, 2001
     – 2002
  • Yale University: Summa Cum Laude, 2002
  • Phi Beta Kappa, 2002
  • USA Funds Access to Education: Scholar, 2002
     – 2006
  • Scholar: Ewha University Alumnae Association, 2003
     – 2004
  • 2004
     -: Louis and Rachel Rudin Scholar, 2004
     – 2006
  • Columbia Residency Program: Hospitalist Resident of the Year, 2009
  • Falcon Award for Patient Care, 2010
  • American College of Gastroenterology: Presidential Poster Award, 2011
  • American Association for the Study of Liver Diseases: Advanced/Transplant Hepatology Fellowship Award, 2013
  • University of Southern California: USC Division of Gastrointestinal and Liver Diseases Faculty Teacher of the Year, 2015
     – 2016
  • University of Southern California: USC Internal Medicine Residency Subspecialty Faculty Teacher of the Year, 2016
     – 2017
  • University of Southern California: USC Internal Medicine Residency Subspecialty Faculty Teacher of the Year, 2018
     – 2019
  • American Liver Foundation: American Liver Foundation (ALF) Liver Health Poster Competition Winner, 2021
  • University of Southern California: USC Transplant Hepatology Faculty Teacher of the Year, 2021
     – 2022
  • University of Southern California: USC Transplant Hepatology Faculty Teacher of the Year, 2022
     – 2023
  • University of Southern California: USC Transplant Hepatology Faculty Teacher of the Year, 2023
     – 2024

Education and Training

  • Yale University, New Haven, CT — BS — 06/2002 — Molecular, Cellular, and Developmental Biology
  • Columbia University, New York, NY — MD — 06/2006 — Medicine
  • Columbia University, New York, NY — 06/2009 — Internal Medicine
  • Johns Hopkins Hospital, Baltimore, MD — 06/2013 — Gastroenterology
  • Mount Sinai Hospital, New York, NY — 06/2014 — Transplant Hepatology

Publications

  • Shared Mechanistic Pathways in Bullous Pemphigoid, Chronic Spontaneous Urticaria, Prurigo Nodularis, and Chronic Prurigo of Unknown Origin: Implications for Targeted Therapies. Am J Clin Dermatol. 2026 Jul 24.. View in PubMed
  • Activation of the auricular vagus nerve reflex suppresses airway inflammation. Immunity. 2026 Jul 15.. View in PubMed
  • IL-13 signaling in cDC2 is required for systemic anaphylactic responses. Proc Natl Acad Sci U S A. 2026 Jul 14; 123(28):e2608478123.. View in PubMed
  • Induction of human pruriceptors from pluripotent stem cells via transcription factors. Stem Cell Reports. 2026 Jul 09; 103004.. View in PubMed
  • The evolving understanding of prurigo nodularis. Clin Exp Dermatol. 2026 Jul 08.. View in PubMed
  • Neuronal responses to cytokines limit intestinal hypermotility and systemic effects of colonic inflammation. iScience. 2026 Jun 19; 29(6):116291.. View in PubMed
  • Restoring balance in atopic disorders: insights into type 2 immunity and chronic inflammation. Front Immunol. 2026; 17:1793641.. View in PubMed
  • Correction: Dupilumab Reduces Pruritus in Clinically Distinct Dermatologic Diseases: Data from Clinical Trials on Atopic Dermatitis, Prurigo Nodularis, and Chronic Spontaneous Urticaria. Dermatol Ther (Heidelb). 2026 Apr; 16(4):1997-2000.. View in PubMed
  • Dupilumab subgroup responder analysis: a post hoc analysis from LIBERTY PRIME and PRIME2 in prurigo nodularis. J Dermatolog Treat. 2026 Dec; 37(1):2626213.. View in PubMed
  • Dupilumab Improves Daily Symptom Burden in Adult Patients with Prurigo Nodularis: Post Hoc Analysis from LIBERTY PN-PRIME and PRIME2 Studies. Dermatol Ther (Heidelb). 2026 Mar; 16(3):1767-1778.. View in PubMed